WHITEHAWK THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number of 11.13 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 11.13M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 8.24M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 8.12M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 7.51M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number as first filed |
|---|---|---|
| 2026-06-30 | 11.13M shares 10-Q · filed 2026-08-06 | |
| 2026-03-31 | 8.24M shares 10-Q · filed 2026-05-07 | |
| 2025-12-31 | 8.12M shares 10-Q · filed 2026-08-06 | |
| 2025-09-30 | 7.51M shares 10-Q · filed 2025-11-06 | |
| 2025-06-30 | 7.59M shares 10-Q · filed 2025-08-07 | |
| 2025-03-31 | 5.33M shares 10-Q · filed 2025-05-08 | |
| 2024-12-31 | 4.95M shares 10-K · filed 2026-03-12 | |
| 2024-09-30 | 5.26M shares 10-Q · filed 2024-11-06 | |
| 2024-06-30 | 5.45M shares 10-Q · filed 2024-08-07 | |
| 2024-03-31 | 5.37M shares 10-Q · filed 2024-05-08 | |
| 2023-12-31 | 4.58M shares 10-K · filed 2025-03-28 | |
| 2023-09-30 | 4.12M shares 10-Q · filed 2023-11-08 | |
| 2023-06-30 | 4.09M shares 10-Q · filed 2023-08-09 | |
| 2023-03-31 | 3.85M shares 10-Q · filed 2023-05-10 | |
| 2022-12-31 | 2.99M shares 10-K · filed 2024-03-13 | |
| 2022-09-30 | 2.94M shares 10-Q · filed 2022-11-09 | |
| 2022-06-30 | 2.74M shares 10-Q · filed 2022-08-10 | |
| 2022-03-31 | 2.03M shares 10-Q · filed 2022-05-12 | |
| 2021-12-31 | 1.75M shares 10-K · filed 2023-03-29 | |
| 2021-09-30 | 1.30M shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 4.63M shares 10-Q · filed 2021-08-11 | |
| 2021-03-31 | 4.49M shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 390.95K shares 10-K · filed 2022-03-17 | 4.64M shares 10-K · filed 2021-03-11 |
| 2020-09-30 | 4.85M shares 10-Q · filed 2020-11-10 | |
| 2020-06-30 | 4.85M shares 10-Q · filed 2020-08-12 | |
| 2020-03-31 | 4.77M shares 10-Q · filed 2020-05-07 | |
| 2019-12-31 | 5.34M shares 10-K · filed 2021-03-11 | |
| 2019-09-30 | 6.73M shares 10-Q · filed 2019-11-07 | |
| 2019-06-30 | 6.77M shares 10-Q · filed 2019-08-08 | |
| 2019-03-31 | 5.17M shares 10-Q · filed 2019-05-09 | |
| 2018-12-31 | 3.35M shares 10-K · filed 2021-03-11 | |
| 2018-09-30 | 3.35M shares 10-Q · filed 2018-11-07 | |
| 2018-06-30 | 3.29M shares 10-Q · filed 2018-08-14 | |
| 2018-03-31 | 1.90M shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 1.91M shares 10-K · filed 2020-03-16 | |
| 2017-09-30 | 898.96K shares 10-Q · filed 2017-11-13 | |
| 2017-06-30 | 898.96K shares 10-Q · filed 2017-08-10 | |
| 2017-03-31 | 924.71K shares 10-Q · filed 2017-05-15 | |
| 2016-12-31 | 927.59K shares 10-K · filed 2019-03-07 | |
| 2015-12-31 | 907.49K shares 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |